Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | DRD5 | P21918 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1741603 | 0.89 | SKP2 (0.48) | SKP2NPC1HPGDMAPK1HTT | |
| SCHEMBL6885851 | 0.86 | SKP2 (0.46) | SKP2NPC1HPGDMAPK1HTT | |
| SCHEMBL11384499 | 0.84 | SKP2 (0.44) | SKP2NPC1HPGDMAPK1HTT | |
| SCHEMBL10527233 | 0.84 | SKP2 (0.44) | SKP2NPC1HPGDMAPK1HTT | |
| SCHEMBL28108936 | 0.84 | SKP2 (0.44) | SKP2NPC1HPGDMAPK1HTT | |
| SCHEMBL455762 | 0.82 | — | — | |
| SCHEMBL25262266 | 0.81 | KDM4E (0.42) | NPC1HPGDMAPK1HTTRAB9A | |
| SCHEMBL7957864 | 0.81 | TDP1 (0.38) | SKP2 | |
| SCHEMBL15067323 | 0.80 | CNR1 (0.42) | CNR1CNR2SKP2LPLLIPG | |
| SCHEMBL8902334 | 0.79 | ESR1 (0.38) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752494-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METATHESIS CATALYSTS | UMICORE AG & Co. KG (DE) | 2020-12-23 | — | — | EP | claimed |
| WO-2019158485-A1 | REACTIONS OF OLEFIN DERIVATIVES IN THE PRESENCE OF METATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2019-08-22 | — | — | WO | claimed |
| EP-3503999-A1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2019-07-03 | — | — | EP | claimed |
| EP-3496855-A1 | METATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2019-06-19 | — | — | EP | claimed |
| WO-2018038928-A1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | MATERIA, INC. (US) | 2018-03-01 | — | — | WO | claimed |
| WO-2018034931-A1 | METATHESIS CATALYSTS | MATERIA, INC. (US) | 2018-02-22 | — | — | WO | claimed |
| WO-2014107447-A1 | FUNCTIONALIZED POLYMERS | BRIDGESTONE CORPORATION (JP) | 2014-07-10 | — | — | WO | claimed |
| EP-2170864-B1 | PYRIDONE GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS | BRISTOL MYERS SQUIBB CO (US) | 2011-09-14 | — | — | EP | claimed |
| EP-3607002-A1 | COLORANT MIXTURES | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2020-02-12 | — | — | EP | disclosed |
| WO-2019179773-A1 | DIACETAL DERIVATIVES AND THEIR USE AS CLARIFIER | CLARIANT INTERNATIONAL LTD (CH) | 2019-09-26 | — | — | WO | disclosed |
| EP-3543244-A1 | DIACETAL DERIVATIVES AND THEIR USE AS CLARIFIER | Clariant International Ltd (CH) | 2019-09-25 | — | — | EP | disclosed |
| EP-3543286-A1 | POLYMER COMPOSITION COMPRISING DIACETAL DERIVATIVES | Clariant International Ltd (CH) | 2019-09-25 | — | — | EP | disclosed |
| EP-3503999-A1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2019-07-03 | — | — | EP | disclosed |
| EP-3496855-A1 | METATHESIS CATALYSTS | UMICORE AG & CO. KG (DE) | 2019-06-19 | — | — | EP | disclosed |
| US-20050209253-A1 | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-09-22 | — | — | US | disclosed |
| EP-1467997-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-20 | — | — | EP | disclosed |
| WO-2004058767-A1 | PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-07-15 | — | — | WO | disclosed |
| CN-1174205-A | Carrier catalyst system, its prep, and use in polymerization of olefines thereof | HOECHST AG (DE) | 1998-02-25 | — | — | CN | disclosed |
| US-4713186-A | PHOSPHATE AND GRAPHITE OR INTERCALATION COMPOUND | LONZA LTD. (CH) | 1987-12-15 | — | — | US | disclosed |
| US-3950374-A | INSECTICIDE, NEMATOCIDE, MITICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209253-A1 | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group | HRH2, HRH4, HRH1 | CNR1 40/4885CNR2 37/4885SKP2 925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.